Literature DB >> 9110390

Quality of life: a reflection of symptoms and concerns.

H Glise1, B Hallerbäck, I Wiklund.   

Abstract

BACKGROUND: Upper gastrointestinal complaints are common in the general population. Most patients consulting have no or only minimal markers of disease. It is important to evaluate new methods for the assessment and follow-up of treatment of these new patient groups. METHODS AND
RESULTS: Recent publications on Quality of Life (QOL) and upper gastrointestinal disease are reviewed with the specific aim of relating the effect of disease symptoms and patient concerns to the outcome of investigations. We found that QOL is adversely affected in upper gastrointestinal disorders and that effective treatment medically or surgically normalizes the scores. There is a good correlation between degree of symptoms and QOL outcome. Patients' concern affects the outcome.
CONCLUSION: QOL assessments are helpful in evaluating the impact of upper gastrointestinal disease.

Entities:  

Mesh:

Year:  1996        PMID: 9110390     DOI: 10.3109/00365529609095545

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  11 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 2.  Heterogeneity of endoscopy negative heartburn: epidemiology and natural history.

Authors:  Fabio Pace; Valentina Casini; Stefano Pallotta
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

3.  Development of a frequent heartburn index.

Authors:  Donald E Stull; Patricia van Hanswijck de Jonge; Katherine Houghton; Christopher Kocun; David W Sandor
Journal:  Qual Life Res       Date:  2011-01-12       Impact factor: 4.147

4.  Gastroesophageal reflux disease and physical activity.

Authors:  Pawel Jozkow; Dorota Wasko-Czopnik; Marek Medras; Leszek Paradowski
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  Pantoprazole on-demand effectively treats symptoms in patients with gastro-oesophageal reflux disease.

Authors:  Theo Scholten; Iris Teutsch; Martina Bohuschke; Gudrun Gatz
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

6.  Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure.

Authors:  Fabio Pace; Stefano Pallotta; Gianpiero Manes; Annalisa de Leone; Patrizia Zentilin; Luigi Russo; Vincenzo Savarino; Matteo Neri; Enzo Grossi; Rosario Cuomo
Journal:  World J Gastroenterol       Date:  2009-12-07       Impact factor: 5.742

7.  Quality of life in patients with subjective food hypersensitivity: applicability of the 10-item short form of the Nepean Dyspepsia Index.

Authors:  Gülen Arslan; Ragna Lind; Snorri Olafsson; Erik Florvaag; Arnold Berstad
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

8.  Effects of omeprazole on symptoms and quality of life in Japanese patients with reflux esophagitis: final results of OMAREE, a large-scale clinical experience investigation.

Authors:  Shigeru Yoshida; Masahiro Nii; Masataka Date
Journal:  BMC Gastroenterol       Date:  2011-02-28       Impact factor: 3.067

9.  Hangekobokuto (Banxia-houpo-tang), a Kampo Medicine that Treats Functional Dyspepsia.

Authors:  Tetsuro Oikawa; Go Ito; Takayuki Hoshino; Hidehiko Koyama; Toshihiko Hanawa
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-04       Impact factor: 2.629

10.  Improvement of reflux symptom related quality of life after Helicobacter pylori eradication therapy.

Authors:  Kenro Hirata; Hidekazu Suzuki; Juntaro Matsuzaki; Tatsuhiro Masaoka; Yoshimasa Saito; Toshihiro Nishizawa; Eisuke Iwasaki; Seiichiro Fukuhara; Sawako Okada; Toshifumi Hibi
Journal:  J Clin Biochem Nutr       Date:  2013-03-01       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.